Hostname: page-component-848d4c4894-ttngx Total loading time: 0 Render date: 2024-05-14T18:44:55.803Z Has data issue: false hasContentIssue false
  • English
  • Français

NeuroAIDS in West Africa: A Full Circle

Published online by Cambridge University Press:  02 December 2014

Christopher Power
Christopher Power*
Affiliation:
Edmonton, Alberta
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Canadian Journal of Neurological Sciences , Volume 34 , Issue 2 , May 2007 , pp. 118 - 119
Copyright
Copyright © The Canadian Journal of Neurological 2007

References

1. Power, C. Retroviral diseases of the nervous system: pathogenic host response or viral gene-mediated neurovirulence? Trends Neurosc. 2001; 24(3):162-9.Google Scholar
2. McArthur, JC, Brew, BJ, Nath, A. Neurological complications of HIV infection. Lancet Neurol. 2005; 4(9):543-55.Google Scholar
3. Dore, GJ, Correll, PK, Li, Y, Kaldor, JM, Cooper, DA, Brew, BJ. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. Aids. 1999; 13(10):1249-53.Google Scholar
4. Ferrando, S, van Gorp, W, McElhiney, M, Goggin, K, Sewell, M, Rabkin, J. Highly active antiretroviral treatment in HIV infection:benefits for neuropsychological function. AIDS. 1998; 12:F65-70.Google Scholar
5. Tozzi, V, Balestra, P, Galgani, S, Narciso, P, Ferri, F, Sebastiani, G, et al. Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment. Aids. 1999; 13(14):1889-97.Google Scholar
6. Sacktor, N, Lyles, RH, Skolasky, R, Kleeberger, C, Selnes, OA, Miller, EN, et al. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology. 2001; 56(2):257-60.Google Scholar
7. Price, RW, Yiannoutos, T, Clifford, DB, Zaborski, L, Tselis, A, Sidtis, JJ, et al. Neurological outcomes in late HIV infection:adverse impact of neurological survival and protection effect of antiretroviral therapy. AIDS. 1999; 13:1677-85.Google Scholar
8. Letendre, SL, McCutchan, JA, Childers, ME, Woods, SP, Lazzaretto, D, Heaton, RK, et al. Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders. Ann Neurol. 2004; 56(3):416-23.Google Scholar
9. Jones, G, Power, C. Regulation of neural cell survival by HIV-1 infection. Neurobiol Dis. 2006; 21(1):1-17.Google ScholarPubMed
10. Anthony, IC, Ramage, SN, Carnie, FW, Simmonds, P, Bell, JE. Influence of HAART on HIV-related CNS disease and neuroinflammation. J Neuropathol Exp Neurol. 2005; 64(6): 529-36.Google Scholar
11. Seines, OA. Memory loss in persons with HIV/AIDS: assessment and strategies for coping. AIDS. Read 2005; 15(6):289-92, 294.Google Scholar
12. Maj, M, Satz, P, Janssen, R, Zaudig, M, Starace, F, D’Elia, L, et al. WHO Neuropsychiatric AIDS study, cross-sectional phase II. Neuropsychological and neurological findings. Arch Gen Psychiatry. 1994; 51(1):51-61.Google ScholarPubMed
13. Sacktor, N, Nakasujja, N, Skolasky, R, Robertson, K, Wong, M, Musisi, S, et al. Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa. Neurology. 2006; 67(2):311-14.Google Scholar
14. Sharp, PM, Bailes, E, Chaudhuri, RR, Rodenburg, CM, Santiago, MO, Hahn, BH. The origins of acquired immune deficiency syndrome viruses: where and when? Philos Trans R Soc Lond B Biol Sci. 2001; 356(1410):867-76.Google Scholar
15. Odaise, FE, Ogunrun, OA, Ogunniyi, AA. Memory performance in HIV/AIDS - a prospective case control study. Can J Neurol Sci. 2007; 34(2):154-159.Google Scholar
16. Zeh, C, Pieniazek, D, Agwale, SM, Robbins, KE, Odama, L, Sani-Gwarzo, N, et al. Nigerian HIV type 2 subtype A and B from heterotypic HIV type 1 and HIV type 2 or monotypic HIV type 2 infections. AIDS Res Hum Retroviruses. 2005; 21(1):17-27.Google Scholar
17. Wong, MH, Robertson, K, Nakasujja, N, Skolasky, R, Musisi, S, Katabira, E, et al. Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa. Neurology. 2007; 68(5):350-5.Google Scholar
18. Bhigjee, AI. Neurological manifestations of HIV infection in Kwazulu-Natal South Africa. J Neurovirol. 2005; 11 Suppl 1: 17-21.Google Scholar